Search Results

Search

Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Click here to read the transcript.

G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.

Video

Recorded on June 22, 2021

 

Neurology Patient Care

Audio

 

Conflict of Interest Disclosure

Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Visibility and Measurability in Health Care Off

Ethics Talk: Social Isolation, Loneliness, and COVID-19

Submitted by gale.saulsberr… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Carla Perissinotto about the health consequences of social isolation and loneliness during the COVID-19 pandemic.

Click here to read the transcript. 

Carla Perissinotto, MD, MHS is an associate professor of medicine at the University of California, San Francisco.

Video

 

Geriatrics Patient Care

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image videocast7-2006 Issue Portraiture in Health Care CME Off
Medicine and Society
Jul 2021

Questioning Biomedicine’s Privileging of Disease and Measurability

Camille Kroll, MA
Adhering too strictly to biomedical thinking about diagnosis can prevent clinicians from empathically engaging with patients and helping them navigate their illness experiences.
AMA J Ethics. 2021;23(7):E537-541. doi: 10.1001/amajethics.2021.537.
Medicine and Society
Jul 2021

How Pharmaceuticals Mask Health and Social Inequity

Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD
Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible.
AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Art of Medicine
Sep 2020

Data, Decisions, White Coats

Christine Lynn Chen
This pen and ink drawing reimagines a white coat in the context of medicine’s realistic, not idealized, dynamism.
AMA J Ethics. 2020;22(9):E818-820. doi: 10.1001/amajethics.2020.818.
Viewpoint
Jun 2008

Medical Care for the Elderly: Should Limits Be Set? Commentary 1

Daniel Callahan, PhD
Should old folks who have lived their lives be allowed to place a huge economic burden on the young by using a disproportionate amount of limited Medicare resources for medical care?
Virtual Mentor. 2008;10(6):404-407. doi: 10.1001/virtualmentor.2008.10.6.oped1-0806.
Case and Commentary
Dec 2008

Role of Schools in Monitoring Student Health

Benjamin Caballero, MD, PhD
This case poses two important questions. First, do schools have the right or the duty to monitor students’ health status measures and require action from parents and, second, what is the role of a student’s primary care physician in this context?
Virtual Mentor. 2008;9(12):790-793. doi: 10.1001/virtualmentor.2007.9.12.ccas1-0712.